Company Overview of Medarex, Inc.
Medarex, Inc. engages in the discovery, development, and commercialization of human antibody-based therapeutics to treat cancer, inflammation, autoimmune disorders, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. It has research facilities in Milpitas and Sunnyvale, California; a research and development facility in Greenwich Township, New Jersey; and a manufacturing facility in Annandale, New Jersey. As of August 31, 2009, Medarex, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
707 State Road
Princeton, NJ 08540-1437
Founded in 1987
Key Executives for Medarex, Inc.
Similar Private Companies By Industry
|SD Pharmaceuticals Inc.||United States|
|NanoMed Pharmaceuticals, Inc.||United States|
|Life Source, Inc.||United States|
|Abide Therapeutics, Inc.||United States|
|Ambry Genetics Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Adelphi, MD | University of Maryland University CollegePosted: May 07
- Milwaukee, WI | Robert W. BairdPosted: Apr 19
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
To contact Medarex, Inc., please visit www.medarex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.